{
    "code": "01056777",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01056777",
    "time": "2021-10-08 08:21:29",
    "許可證字號": "衛署藥製字第056777號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/19",
    "發證日期": "101\/01\/19",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105677708",
    "中文品名": "&quot;台灣神隆&quot;瑞隆首",
    "英文品名": "Riluzole &quot;SPT&quot;",
    "適應症": "肌萎縮脊髓側索硬化症。",
    "劑型": "040（粉）",
    "包裝": "0.5公斤以上HDPE圓桶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "01國　產",
    "申請商名稱": "1437920200  台灣神隆股份有限公司",
    "申請商地址": "台南市善化區南科八路１號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "29342090004 其他結構式中含苯駢?唑環（不論是否氫化）之化合物，未經進一步稠合者Other compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fused",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "SPT1011 英文Label (20041227)___20120319.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056777&Seq=002&Type=8"
        }
    ]
}